The higher prevalence of missense mutations in hemophilia B compared to hemophilia A could be important in determining a milder clinical phenotype in patients with severe hemophilia B

Benzer Materyaller

• A contribution to the debate about the possible different clinical severity between hemophilia A and B
  Yazar:: Melchiorre, Daniela, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Why should hemophilia B be milder than hemophilia A?
  Yazar:: Shetty, Shrimati, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A
  Yazar:: Melchiorre, Daniela, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• A milder clinical course for severe hemophilia B: a true or biased effect?
  Yazar:: van Miert, Jasper H.A., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
  Yazar:: Linari, Silvia, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)